KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to 1PHIA. 1PHIA was compared to 54 industry peers in the Health Care Equipment & Supplies industry. 1PHIA may be in some trouble as it scores bad on both profitability and health. 1PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
In the past year 1PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
1PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
1PHIA has a Return On Assets of -2.42%. This is comparable to the rest of the industry: 1PHIA outperforms 46.30% of its industry peers.
The Return On Equity of 1PHIA (-5.85%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1PHIA's Operating Margin has declined in the last couple of years.
1PHIA has a Gross Margin of 43.13%. This is in the lower half of the industry: 1PHIA underperforms 66.67% of its industry peers.
1PHIA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for 1PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
1PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1PHIA has been reduced compared to 1 year ago.
Compared to 5 years ago, 1PHIA has more shares outstanding
Compared to 1 year ago, 1PHIA has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.58, we must say that 1PHIA is in the distress zone and has some risk of bankruptcy.
1PHIA has a Altman-Z score (1.58) which is in line with its industry peers.
1PHIA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as 1PHIA would need 8.68 years to pay back of all of its debts.
1PHIA's Debt to FCF ratio of 8.68 is in line compared to the rest of the industry. 1PHIA outperforms 59.26% of its industry peers.
1PHIA has a Debt/Equity ratio of 0.59. This is a neutral value indicating 1PHIA is somewhat dependend on debt financing.
1PHIA has a Debt to Equity ratio (0.59) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.58 |
ROIC/WACCN/A
WACC6.24%
2.3 Liquidity
1PHIA has a Current Ratio of 1.23. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
1PHIA has a Current ratio (1.23) which is comparable to the rest of the industry.
A Quick Ratio of 0.84 indicates that 1PHIA may have some problems paying its short term obligations.
The Quick ratio of 1PHIA (0.84) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
1PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.72%, which is quite good.
1PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
1PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.82%.
1PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
3.2 Future
The Earnings Per Share is expected to grow by 12.99% on average over the next years. This is quite good.
1PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.55% yearly.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1PHIA is valuated correctly with a Price/Earnings ratio of 15.22.
Based on the Price/Earnings ratio, 1PHIA is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.98, 1PHIA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.89, the valuation of 1PHIA can be described as correct.
Based on the Price/Forward Earnings ratio, 1PHIA is valued a bit cheaper than 79.63% of the companies in the same industry.
1PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.22 | ||
| Fwd PE | 13.89 |
4.2 Price Multiples
64.81% of the companies in the same industry are more expensive than 1PHIA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1PHIA is valued cheaper than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.6 | ||
| EV/EBITDA | 18.19 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1PHIA's earnings are expected to grow with 12.13% in the coming years.
PEG (NY)1.53
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
1PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (4/22/2025, 7:00:00 PM)
21.16
+1.03 (+5.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap19.89B
Analysts73.08
Price Target28.96 (36.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.27%
Min EPS beat(2)-16.56%
Max EPS beat(2)-11.97%
EPS beat(4)0
Avg EPS beat(4)-12.16%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.79%
EPS beat(12)3
Avg EPS beat(12)3.3%
EPS beat(16)5
Avg EPS beat(16)1.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-2.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-2.44%
PT rev (1m)0.11%
PT rev (3m)0.73%
EPS NQ rev (1m)-12.16%
EPS NQ rev (3m)-2.2%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-8.98%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.22 | ||
| Fwd PE | 13.89 | ||
| P/S | 1.1 | ||
| P/FCF | 22.6 | ||
| P/OCF | 12.78 | ||
| P/B | 1.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.19 |
EPS(TTM)1.39
EY6.57%
EPS(NY)1.52
Fwd EY7.2%
FCF(TTM)0.94
FCFY4.42%
OCF(TTM)1.66
OCFY7.82%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.53
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.58 |
F-Score6
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year57.53%
EBIT Next 3Y22.84%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%